Introduction
Every rapid test strip that reaches a clinic, pharmacy, or field health worker starts its life as a set of raw chemical materials and polymer membranes, and what happens between those two points determines whether the test is reliable or not.
Understanding rapid test strip manufacturing helps procurement officers evaluate suppliers intelligently, gives factory auditors a framework for meaningful inspections, and lets distributors explain product quality to their end customers with confidence.
Neo Nostics (Suzhou) Bioengineering Co., Ltd. has manufactured lateral flow in vitro diagnostic (IVD) products since 2015. With a monthly production capacity of 1.5 million tests and exports reaching more than 80 countries, the company runs a tightly controlled 12-step production process built around CE certification and ISO 13485 quality management standards.
This article walks through each step, identifies the critical control points that separate consistent products from variable ones, and explains what auditors should look for at every stage.
The 12 Steps of Rapid Test Strip Manufacturing
Step 1: Incoming Raw Material Inspection
Rapid test strip manufacturing begins before a single reagent touches a membrane. Incoming materials, nitrocellulose (NC) membranes, conjugate pads, absorbent pads, backing cards, antibodies, and antigens, each undergo documented acceptance testing against predefined specifications. Suppliers submit certificates of analysis (CoA), and the QC team verifies key parameters independently.
NC membrane lot testing is particularly critical at this stage. Membrane pore size directly controls the capillary flow rate of the sample, which affects both sensitivity and specificity of the final test. Accepting an off-spec membrane lot can compromise an entire production run. A compliant supplier rejects non-conforming batches and quarantines them before production begins.
Step 2: Colloidal Gold Nanoparticle Synthesis
The colloidal gold conjugate is the detection engine of every lateral flow strip. Manufacturers produce gold nanoparticles by reducing chloroauric acid with sodium citrate under controlled temperature and pH conditions. Particle size, typically 20–40 nm for most diagnostic applications, governs signal intensity and color visibility on the test line.
Batch-to-batch particle size consistency is one of the most demanding quality controls in the entire IVD manufacturing process. Laboratories measure particle diameter using transmission electron microscopy (TEM) or dynamic light scattering (DLS), and acceptable batches show a narrow, reproducible size distribution. Inconsistent particle synthesis produces tests that display variable line intensity, making results harder to interpret.
Step 3: Antibody or Antigen Conjugation
Once gold nanoparticles pass the size specification, technicians conjugate them to detector antibodies or antigens specific to the target analyte. The conjugation reaction attaches proteins to the gold surface via electrostatic and hydrophobic interactions. Conjugate quality, measured by activity, binding capacity, and stability, determines the sensitivity of the finished strip.
After conjugation, the conjugate solution undergoes blocking with bovine serum albumin (BSA) or casein to prevent non-specific binding, followed by centrifugation and resuspension in a stabilizing buffer. The team tests each conjugate lot for reactivity before it enters the dispensing step.
Step 4: Conjugate Pad Dispensing
The conjugate pad holds the labeled detector in a dried, mobile form. Precision dispensing equipment sprays or prints a defined volume of conjugate solution, measured in microliters per centimeter, onto the glass fiber or polyester conjugate pad material. Dispensing volume uniformity directly controls how much conjugate mobilizes when sample fluid wicks through the strip.
Automated dispensing equipment plays a central role in achieving intra-batch and inter-batch precision here. Manual or semi-automated dispensing introduces operator-dependent variability.
At Neo Nostics, ongoing investment in automated dispensing technology targets batch-to-batch coefficient of variation (CV) at ≤15%, consistent with the company’s internal QC standard. The next generation of automated dispensing lines the company is commissioning will push precision further as part of its process optimization roadmap.
Step 5: Nitrocellulose Membrane Coating
The NC membrane carries the test line (T line) and control line (C line), the two lines that readers use to interpret results. An automated membrane sprayer deposits precise volumes of capture antibody (for the T line) and secondary antibody or anti-species antibody (for the C line) in defined positions.
Line position accuracy, line width, and antibody concentration per unit length all affect assay sensitivity. A deviation as small as 0.5 mm in line position can shift a quantitative result outside its acceptable range. Manufacturers validate each membrane coating run with reference samples before releasing the lot for lamination.
Step 6: Membrane and Pad Drying
After coating, the membranes and conjugate pads move through controlled drying chambers. Temperature and relative humidity during drying affect protein conformation, binding activity, and the final flow characteristics of the strip. Most IVD facilities maintain drying rooms at 20–25°C with relative humidity between 20% and 30%.
Underdrying leaves residual moisture that degrades proteins during storage and shortens shelf life. Overdrying can denature the antibody coating and reduce test sensitivity. Validated drying curves time, temperature, and humidity profiles) form part of the batch production record for each product.
Step 7: Lamination (Membrane Stack Assembly)
Lamination assembles the individual components, conjugate pad, NC membrane, absorbent pad, and backing card, into a single laminated sheet. Automated lamination machines align each layer to within fractions of a millimeter and apply consistent adhesive pressure across the full sheet width.
Misalignment at this step introduces capillary flow irregularities. If the conjugate pad overlaps the NC membrane by too much, the sample front accelerates and reduces contact time with the test and control lines, lowering sensitivity. Precise lamination is therefore a direct determinant of clinical performance.
Step 8: Slitting and Cutting
The laminated sheet passes through precision slitting blades that cut it into individual strips of a defined width, typically 3–4 mm for cassette-format tests and up to 5–6 mm for dipstick formats. Blade sharpness and cutting speed matter here: dull blades compress the strip edge, restricting lateral wicking.
Each production batch generates strip width measurements at defined intervals. The QC team checks that all strips fall within the specified width tolerance, usually ±0.1 mm, before they move to assembly.
Step 9: Cassette or Card Assembly
For cassette-format tests, individual strips load into plastic housing components. Assembly lines fit the strip into the lower cassette shell, snap the upper housing in place, and verify that the membrane windows align correctly with the result viewing area. For strip card formats, the cut strips mount directly onto backing cards.
Assembly line auditors check for cosmetic defects, cracks in housing, misaligned windows, or loose strip movement inside the cassette, as part of a defined sampling plan. At Neo Nostics, 100+ production staff operate across assembly lines with a factory area exceeding 12,000 m², allowing simultaneous production of multiple product lines without cross-contamination risk.
Step 10: In-Process and Finished Product Quality Control
Quality control testing runs at multiple points in the rapid test strip manufacturing process, not only at the end. Finished product QC tests each batch against a panel of positive and negative reference standards covering the clinical detection range.
Key QC metrics include:
- Intra-batch precision (CV): ≤15%, meaning strips within a single production run perform consistently.
- Inter-batch precision (CV): ≤15%, meaning separate production batches deliver equivalent results.
- Sensitivity and specificity: Validated against clinical sample panels for each product.
Batches that fail any QC criterion undergo investigation before rejection or rework. No non-conforming batch advances to packaging under the ISO 13485 quality management system.
Step 11: Packaging
Strips or cassettes pass into individual foil pouches together with a desiccant sachet. The foil pouch sealing process uses validated heat-seal parameters, temperature, pressure, and dwell time, to achieve a hermetic seal that protects the strip from humidity throughout its shelf life.
Outer packaging (boxes and cartons) receives lot number, manufacture date, expiry date, storage conditions, and all regulatory markings required for the target market. Products carrying CE marking include IFU (instructions for use) documentation in the languages required by the destination country.
Step 12: Batch Release
The final step in rapid test strip manufacturing is formal batch release. A qualified person reviews the complete batch production record, raw material CoAs, in-process QC data, finished product test results, packaging inspection records, and environmental monitoring logs, and signs off before the batch ships.
Products reach customers with a 24-month shelf life at room temperature, validated through accelerated and real-time stability studies. The standard production lead time from Neo Nostics is 5 working days for stock products, though lead time scales with order volume. The minimum order quantity (MOQ) is 1,000 tests, making the range accessible for distributors building new market positions as well as high-volume procurement programs.
What Factory Auditors Should Examine at Each Stage
Procurement auditors visiting a rapid test strip manufacturer should move beyond a general facility tour and check these specific areas:
- Raw material quarantine and release records: Confirm that every incoming material lot has a documented acceptance decision and that rejected lots carry clear quarantine labels.
- Colloidal gold particle size testing records: Request TEM or DLS data for the last five gold batches and check size distribution consistency.
- Automated dispensing calibration logs: Verify that dispensing equipment undergoes routine calibration, and that volume consistency data appears in the batch record.
- Environmental monitoring data: Ask for temperature and humidity records from production and drying rooms over a 90-day period.
- Finished product QC sampling plan: Confirm the sample size per batch and the acceptance criteria for positive and negative controls.
- Stability study reports: Request real-time and accelerated stability data that support the claimed 24-month shelf life.
- Non-conformance and CAPA records: Review how the manufacturer identifies, investigates, and closes out quality failures.
A manufacturer holding CE certification and ISO 13485 registration provides a documented baseline for all seven areas. Neo Nostics carries both certifications and supports factory audits by customers and regulatory bodies across its export markets in Europe, Southeast Asia, and Africa.
Looking Ahead: Where Rapid Test Strip Manufacturing Is Heading
Rather than discussing generic market trends, it is worth noting the specific technical developments that responsible IVD manufacturers are actively pursuing. Neo Nostics is working on two priority initiatives:
First, multiplex test card development engineering single cassettes that detect 2 to 5 biomarkers simultaneously. A single patient sample that can rule in or rule out multiple co-circulating pathogens in one lateral flow test dramatically reduces the cost and time burden on health systems in resource-limited settings.
Second, automated dispensing line upgrades replace semi-automated dispensing with fully automated systems that monitor volume deposition in real time. These upgrades target further reduction of inter-batch CV and are designed to support the scale of production that government tender programs and large distribution networks require.
Both programs reflect the company’s view that the colloidal gold lateral flow format still has significant headroom for improvement in precision, throughput, and clinical information density.
Conclusion
Rapid test strip manufacturing is a multi-step, highly controlled process where decisions made in the first few steps- particle synthesis, conjugation, and membrane coating- determine the clinical reliability of the finished product. Understanding these 12 steps gives procurement officers, auditors, and distributors the language to evaluate suppliers critically rather than accepting surface-level quality claims.
Neo Nostics (Suzhou) Bioengineering Co., Ltd. operates this complete 12-step process under CE and ISO 13485 certification, with a monthly output of 1.5 million tests and a documented intra- and inter-batch CV of ≤15%. Shelf-life-validated products ship within 5 working days for standard orders, with OEM customization available from a 1,000-test MOQ.
Ready to Audit Our Manufacturing Process?
Request Samples to evaluate finished product quality before committing to a purchase order.
Consult Our OEM Solutions: Discuss product customization, branding, and regulatory documentation for your market.
Schedule a Factory Audit: Book an in-person or virtual walkthrough of the Neo Nostics production facility in TaiCang, SuZhou.
